Test Bank Complete_
Lehne's Pharmacotherapeutics For Advanced Practice
Nurses And Physician Assistants 3rd Edition, (2024)
By Laura D. Rosenthal & Jacqueline Rosenjack Burchum
All Chapters 1-94| 20 Units| Latest Edition With Detailed Answers| Grade A+
From: [Bestmaxsolutions.stuvia
,UNIT I: INTRODUCTION ---------------------------------------------------------------------- 6
Chapter 1: Prescriptive Authority ------------------------------------------------------------------ 6
Chapter 2: Rational Drug Selection And Prescription Writing ------------------------------ 12
Chapter 3: Promoting Positive Outcomes Of Drug Therapy --------------------------------- 18
UNIT II: BASIC PRINCIPLES OF PHARMACOLOGY --------------------------------- 25
Chapter 4: Pharmacokinetics, Pharmacodynamics, And Drug Interactions -------------- 25
Chapter 5: Adverse Drug Reactions And Medication Errors -------------------------------- 37
Chapter 6: Individual Variation In Drug Responses ------------------------------------------ 49
Chapter 7: Genetic And Genomic Considerations In Pharmacotherapeutics ------------- 59
UNIT III: DRUG THERAPY ACROSS THE LIFE SPAN-------------------------------- 70
Chapter 8: Drug Therapy During Pregnancy And BreastFeeding -------------------------- 70
Chapter 9: Drug Therapy In Pediatric Patients ------------------------------------------------ 79
Chapter 10: Drug Therapy In Geriatric Patients ---------------------------------------------- 89
UNIT IV: PERIPHERAL NERVOUS SYSTEM DRUGS -------------------------------- 101
Chapter 11: Basic Principles Of Neuropharmacology ---------------------------------------- 101
Chapter 12: Physiology Of The Peripheral Nervous System -------------------------------- 108
Chapter 13: Muscarinic Agonists And Cholinesterase Inhibitors -------------------------- 116
Chapter 14 Muscarinic Antagonists ------------------------------------------------------------- 125
Chapter 15: Adrenergic Agonists ---------------------------------------------------------------- 132
Chapter 16: Adrenergic Antagonists ------------------------------------------------------------ 143
Chapter 17: Indirect-Acting Antiadrenergic Agents ----------------------------------------- 157
UNIT V: CENTRAL NERVOUS SYSTEM DRUGS -------------------------------------- 167
Chapter 18: Introduction To Central Nervous System Pharmacology -------------------- 167
Chapter 19: Drugs For Parkinson's Disease --------------------------------------------------- 174
Chapter 20: Drugs For Alzheimer's Disease --------------------------------------------------- 183
Chapter 21: Drugs For Seizure Disorders ------------------------------------------------------ 193
Chapter 22: Drugs For Muscle Spasm And Spasticity --------------------------------------- 202
UNIT VI: DRUGS FOR PAIN --------------------------------------------------------------- 211
Chapter 23: Local Anesthetics ------------------------------------------------------------------- 211
Chapter 24: Opioid Analgesics, Opioid Antagonists, And Nonopioid Centrally Acting
Analgesics -------------------------------------------------------------------------------------------- 221
Chapter 25: Drugs For Headache ---------------------------------------------------------------- 234
UNIT VII: PSYCHOTHERAPEUTIC DRUGS -------------------------------------------- 245
Chapter 26: Antipsychotic Agents And Their Use In Schizophrenia ---------------------- 245
Chapter 27: Antidepressants --------------------------------------------------------------------- 259
, Chapter 28: Drugs For Bipolar Disorder ------------------------------------------------------- 269
Chapter 29: Sedative-Hypnotic Drugs ---------------------------------------------------------- 280
Chapter 30: Management Of Anxiety Disorders ---------------------------------------------- 288
Chapter 31: Central Nervous System Stimulants And Attention-Deficit/Hyperactivity
Disorder ---------------------------------------------------------------------------------------------- 297
UNIT VIII: SUBSTANCE USE DISORDERS --------------------------------------------- 307
Chapter 32: Substance Use Disorders I: Basic Considerations ----------------------------- 307
Chapter 33: Substance Use Disorders II: Alcohol --------------------------------------------- 315
Chapter 34: Substance Use Disorders III: Nicotine And Smoking ------------------------- 326
Chapter 35: Substance Use Disorders Iv: Major Drugs Of Abuse Other Than Alcohol
And Nicotine----------------------------------------------------------------------------------------- 335
UNIT IX: DRUGS THAT AFFECT THE HEART, BLOOD VESSELS, BLOOD, AND
BLOOD VOLUME ----------------------------------------------------------------------------- 351
Chapter 36: Review Of Hemodynamics --------------------------------------------------------- 351
Chapter 37: Diuretics ------------------------------------------------------------------------------ 358
Chapter 38: Drugs Acting On The Renin-Angiotensin-Aldosterone System -------------- 367
Chapter 39: Calcium Channel Blockers -------------------------------------------------------- 379
Chapter 40: Vasodilators -------------------------------------------------------------------------- 385
Chapter 41: Drugs For Hypertension ----------------------------------------------------------- 394
Chapter 42: Drugs For Heart Failure ----------------------------------------------------------- 410
Chapter 43: Antidysrhythmic Drugs ------------------------------------------------------------ 427
Chapter 44: Prophylaxis Of Atherosclerotic Cardiovascular Disease: Drugs That Help
Normalize Cholesterol And Triglyceride Levels----------------------------------------------- 445
Chapter 45: Drugs For Angina Pectoris -------------------------------------------------------- 461
Chapter 46: Anticoagulant and Antiplatelet Drugs ------------------------------------------- 477
Chapter 47: Drugs For Deficiency Anemias --------------------------------------------------- 492
UNIT X: DRUGS FOR ENDOCRINE DISORDERS ------------------------------------- 504
Chapter 48: Drugs For Diabetes ----------------------------------------------------------------- 504
Chapter 49: Drugs For Thyroid Disorders ----------------------------------------------------- 517
UNIT XI: REPRODUCTIVE HEALTH ---------------------------------------------------- 530
Chapter 50: Estrogens And Progestins: Basic Pharmacology And Noncontraceptive
Applications ----------------------------------------------------------------------------------------- 530
Chapter 51: Birth Control ------------------------------------------------------------------------ 537
Chapter 52: Androgens ---------------------------------------------------------------------------- 551
Chapter 53: Drugs for Benign Prostatic Hyperplasia ---------------------------------------- 560
Chapter 54. Drugs For Sexual Dysfunction ---------------------------------------------------- 566
Chapter 55. Transgender Health ----------------------------------------------------------------- 576
,UNIT XII: ANTI-INFLAMMATORY, ANTIALLERGIC, AND IMMUNOLOGIC
DRUGS ------------------------------------------------------------------------------------------ 600
Chapter 56: Review Of The Immune System -------------------------------------------------- 600
Chapter 57: Childhood Immunization ---------------------------------------------------------- 609
Chapter 58: Antihistamines ----------------------------------------------------------------------- 622
Chapter 59: Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs And
Acetaminophen ------------------------------------------------------------------------------------- 633
Chapter 60: Glucocorticoids In Nonendocrine Disorders------------------------------------ 646
UNIT XIII: DRUGS FOR BONE AND JOINT DISORDERS --------------------------- 659
Chapter 61: Drug Therapy Of Rheumatoid Arthritis ---------------------------------------- 659
Chapter 62: Drug Therapy Of Gout ------------------------------------------------------------- 667
Chapter 63: Drugs Affecting Calcium Levels And Bone Mineralization ------------------ 675
UNIT XIV: RESPIRATORY TRACT DRUGS --------------------------------------------- 688
Chapter 64: Drugs For Asthma And Chronic Obstructive Pulmonary Disease ---------- 688
Chapter 65: Drugs For Allergic Rhinitis, Cough, And Colds ------------------------------- 704
UNIT XV: GASTROINTESTINAL DRUGS ----------------------------------------------- 717
Chapter 66: Drugs For Peptic Ulcer Disease --------------------------------------------------- 717
Chapter 67: Laxatives ----------------------------------------------------------------------------- 727
Chapter 68: Other Gastrointestinal Drugs ----------------------------------------------------- 739
UNIT XVI: NUTRITION AND COMPLEMENTARY THERAPIES ------------------- 756
Chapter 69: Vitamins ------------------------------------------------------------------------------ 756
Chapter 70: Drugs for Obesity ------------------------------------------------------------------- 767
Chapter 71: Complementary And Alternative Therapies------------------------------------ 778
UNIT XVII: THERAPY FOR INFECTIOUS AND PARASITIC DISEASES--------- 786
Chapter 72: Basic Principles Of Antimicrobial Therapy ------------------------------------ 786
Chapter 73: Drugs That Weaken The Bacterial Cell Wall I: Penicillin’s ----------------- 795
Chapter 74: Drugs That Weaken The Bacterial Cell Wall Ii: Other Drugs -------------- 807
Chapter 75: Bacteriostatic Inhibitors Of Protein Synthesis --------------------------------- 817
Chapter 76: Aminoglycosides: Bactericidal Inhibitors Of Protein Synthesis ------------- 834
Chapter 77: Sulfonamide Antibiotics and Trimethoprim ------------------------------------ 848
Chapter 78: Drug Therapy Of Urinary Tract Infections ------------------------------------ 859
Chapter 79: Drugs Therapy For Tuberculosis ------------------------------------------------- 871
Chapter 80: Miscellaneous Antibacterial Drugs ---------------------------------------------- 886
Chapter 81: Antifungal Agents ------------------------------------------------------------------- 894
Chapter 82: Antiviral Agents I: Drugs For Non-Hiv Viral Infections --------------------- 911
Chapter 83: Antiviral Agents II: Drugs for HIV Infection ---------------------------------- 924
, Chapter 84: Drug Therapy for Sexually Transmitted Infections --------------------------- 935
Chapter 85: Anthelmintics ------------------------------------------------------------------------ 944
UNIT XVIII: CANCER THERAPY --------------------------------------------------------- 951
Chapter 86: Introduction To Immunomodulators -------------------------------------------- 951
Chapter 87: Supportive Care of Patients Receiving Anticancer Drugs -------------------- 960
Chapter 88: Drugs for Cancer Pain ------------------------------------------------------------- 973
UNIT XIX: DRUGS FOR EYES, EARS, AND SKIN ------------------------------------- 988
Chapter 89: Drugs for Disorders of the Eye --------------------------------------------------- 988
Chapter 90: Drugs for Disorders of the Skin -------------------------------------------------- 999
Chapter 91: Drugs for Disorders of the Ear ------------------------------------------------- 1016
UNIT XX: DRUG THERAPY IN ACUTE CARE --------------------------------------- 1027
Chapter 92: Agents Affecting The Volume And Ion Content Of Body Fluids ---------- 1027
Chapter 93: Management Of St-Elevation Myocardial Infarction ----------------------- 1037
Chapter 94: Drugs for Acute Care------------------------------------------------------------- 1048
,UNIT I: INTRODUCTION
Chapter 1: Prescriptive Authority
Rosenthal: Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants 3rd Edition, (2024) Test Bank
MULTIPLE CHOICE
1. What Is The Primary Purpose Of Prescriptive Authority For Advanced Practice
Nurses (APNS) And Physician Assistants (PAS)?
A) To Replace Physicians
B) To Enhance Patient Care And Access To Medications
C) To Increase Healthcare Costs
D) To Limit The Roles Of Physicians
Correct Answer: B) To Enhance Patient Care And Access To Medications
Rationale: Prescriptive Authority Allows APNS And PAS To Provide Timely
Medication Management, Improving Patient Access And Outcomes.
2. Which Factor Is Most Commonly Used To Determine The Extent Of
Prescriptive Authority For Apns And Pas?
A) Individual Training Programs
B) State Laws And Regulations
C) Hospital Policies
D) Patient Preferences
Correct Answer: B) State Laws And Regulations
Rationale: The Scope Of Prescriptive Authority Is Primarily Governed By State-
Specific Laws And Regulations.
,3. In Many States, Which Of The Following Is Required For An Np To Prescribe
Controlled Substances?
A) Completion Of A Residency Program
B) Certification From A National Board
C) DEA Registration
D) A Collaborative Agreement With A Pharmacist
Correct Answer: C) DEA Registration
Rationale: Prescribing Controlled Substances Requires Healthcare Providers To
Register With The Drug Enforcement Administration (DEA).
4. Which Of The Following Statements About Collaborative Practice
Agreements Is True?
A) They Are Only Necessary For PAS, Not NPS.
B) They Outline The Supervisory Relationship Between A Physician And An
APN Or PA.
C) They Limit The Medications That Can Be Prescribed.
D) They Are Optional In All States.
Correct Answer: B) They Outline The Supervisory Relationship Between A
Physician And An APN Or PA.
Rationale: Collaborative Practice Agreements Define The Working Relationship,
Including Prescribing Authority And Supervision Details.
5. Which Medication Class Is Most Likely To Require A Prescription?
A) Antacids
B) Antibiotics
,C) NSAIDS
D) Herbal Supplements
Correct Answer: B) Antibiotics
Rationale: Antibiotics Typically Require A Prescription Due To The Need For
Proper Diagnosis And Management Of Potential Side Effects.
6. What Is A Key Benefit Of E-Prescribing For APNS And Pas?
A) It Eliminates The Need For Patient Evaluations.
B) It Enhances Medication Adherence And Reduces Errors.
C) It Increases The Time Spent On Paperwork.
D) It Limits Access To Medications.
Correct Answer: B) It Enhances Medication Adherence And Reduces Errors.
Rationale: E-Prescribing Improves Accuracy And Efficiency, Helping To Ensure
Patients Receive The Correct Medications.
7. Which Of The Following Is Not A Common Requirement For Obtaining
Prescriptive Authority For APNS?
A) Advanced Pharmacology Coursework
B) National Certification
C) A Minimum Of Five Years Of Clinical Experience
D) State-Specific Licensure
Correct Answer: C) A Minimum Of Five Years Of Clinical Experience
Rationale: While Experience Is Valuable, Most States Do Not Require Five
Years Of Clinical Practice Specifically For Prescriptive Authority.
,8. What Role Do Formularies Play In Prescriptive Authority?
A) They Are Optional Lists Of Medications.
B) They Provide Guidelines On Prescribing Controlled Substances.
C) They Outline The Medications That Can Be Prescribed By APNS And Pas.
D) They Limit Prescribing To Generic Medications Only.
Correct Answer: C) They Outline The Medications That Can Be Prescribed By
APNS And PAS.
Rationale: Formularies Specify Which Medications Are Approved For Use By
Specific Providers, Guiding Their Prescribing Practices.
9. Which Of The Following Actions Could Lead To Disciplinary Action Against
An APN Or Pa Regarding Prescriptive Authority?
A) Prescribing A Medication Without A Valid Patient Relationship
B) Following A Collaborative Practice Agreement
C) Using E-Prescribing Systems Correctly
D) Consulting A Physician About Medication Management
Correct Answer: A) Prescribing A Medication Without A Valid Patient
Relationship
Rationale: Prescribing Without A Legitimate Patient-Provider Relationship
Violates Ethical And Legal Standards, Leading To Potential Disciplinary Actions.
10. What Is A Common Barrier To Effective Prescribing By APNS And PAS?
A) Access To Training Programs
B) Availability Of Medications
C) State Regulations That Limit Prescribing Authority
, D) Patient Trust
Correct Answer: C) State Regulations That Limit Prescribing Authority
Rationale: Variations In State Laws Can Restrict The Scope Of Practice And The
Ability To Prescribe Certain Medications.
11. Which Of The Following Is An Important Consideration When Prescribing
Medications?
A) Only The Physician's Preferences
B) The Patient's Medical History And Current Medications
C) Popular Trends In Pharmaceuticals
D) The Cost Of Medications Only
Correct Answer: B) The Patient's Medical History And Current Medications
Rationale: A Thorough Understanding Of A Patient's Medical History And
Current Medications Is Crucial For Safe And Effective Prescribing.
12. Which Of The Following Is True About Prescriptive Authority In Telehealth?
A) It Is Prohibited In All States.
B) It Has The Same Requirements As In-Person Visits.
C) It Allows For Easier Access To Medications Without Evaluations.
D) It Can Only Be Done For Non-Controlled Substances.
Correct Answer: B) It Has The Same Requirements As In-Person Visits.
Rationale: Prescriptive Authority In Telehealth Is Subject To The Same Legal
And Professional Standards As Traditional In-Person Visits.
Lehne's Pharmacotherapeutics For Advanced Practice
Nurses And Physician Assistants 3rd Edition, (2024)
By Laura D. Rosenthal & Jacqueline Rosenjack Burchum
All Chapters 1-94| 20 Units| Latest Edition With Detailed Answers| Grade A+
From: [Bestmaxsolutions.stuvia
,UNIT I: INTRODUCTION ---------------------------------------------------------------------- 6
Chapter 1: Prescriptive Authority ------------------------------------------------------------------ 6
Chapter 2: Rational Drug Selection And Prescription Writing ------------------------------ 12
Chapter 3: Promoting Positive Outcomes Of Drug Therapy --------------------------------- 18
UNIT II: BASIC PRINCIPLES OF PHARMACOLOGY --------------------------------- 25
Chapter 4: Pharmacokinetics, Pharmacodynamics, And Drug Interactions -------------- 25
Chapter 5: Adverse Drug Reactions And Medication Errors -------------------------------- 37
Chapter 6: Individual Variation In Drug Responses ------------------------------------------ 49
Chapter 7: Genetic And Genomic Considerations In Pharmacotherapeutics ------------- 59
UNIT III: DRUG THERAPY ACROSS THE LIFE SPAN-------------------------------- 70
Chapter 8: Drug Therapy During Pregnancy And BreastFeeding -------------------------- 70
Chapter 9: Drug Therapy In Pediatric Patients ------------------------------------------------ 79
Chapter 10: Drug Therapy In Geriatric Patients ---------------------------------------------- 89
UNIT IV: PERIPHERAL NERVOUS SYSTEM DRUGS -------------------------------- 101
Chapter 11: Basic Principles Of Neuropharmacology ---------------------------------------- 101
Chapter 12: Physiology Of The Peripheral Nervous System -------------------------------- 108
Chapter 13: Muscarinic Agonists And Cholinesterase Inhibitors -------------------------- 116
Chapter 14 Muscarinic Antagonists ------------------------------------------------------------- 125
Chapter 15: Adrenergic Agonists ---------------------------------------------------------------- 132
Chapter 16: Adrenergic Antagonists ------------------------------------------------------------ 143
Chapter 17: Indirect-Acting Antiadrenergic Agents ----------------------------------------- 157
UNIT V: CENTRAL NERVOUS SYSTEM DRUGS -------------------------------------- 167
Chapter 18: Introduction To Central Nervous System Pharmacology -------------------- 167
Chapter 19: Drugs For Parkinson's Disease --------------------------------------------------- 174
Chapter 20: Drugs For Alzheimer's Disease --------------------------------------------------- 183
Chapter 21: Drugs For Seizure Disorders ------------------------------------------------------ 193
Chapter 22: Drugs For Muscle Spasm And Spasticity --------------------------------------- 202
UNIT VI: DRUGS FOR PAIN --------------------------------------------------------------- 211
Chapter 23: Local Anesthetics ------------------------------------------------------------------- 211
Chapter 24: Opioid Analgesics, Opioid Antagonists, And Nonopioid Centrally Acting
Analgesics -------------------------------------------------------------------------------------------- 221
Chapter 25: Drugs For Headache ---------------------------------------------------------------- 234
UNIT VII: PSYCHOTHERAPEUTIC DRUGS -------------------------------------------- 245
Chapter 26: Antipsychotic Agents And Their Use In Schizophrenia ---------------------- 245
Chapter 27: Antidepressants --------------------------------------------------------------------- 259
, Chapter 28: Drugs For Bipolar Disorder ------------------------------------------------------- 269
Chapter 29: Sedative-Hypnotic Drugs ---------------------------------------------------------- 280
Chapter 30: Management Of Anxiety Disorders ---------------------------------------------- 288
Chapter 31: Central Nervous System Stimulants And Attention-Deficit/Hyperactivity
Disorder ---------------------------------------------------------------------------------------------- 297
UNIT VIII: SUBSTANCE USE DISORDERS --------------------------------------------- 307
Chapter 32: Substance Use Disorders I: Basic Considerations ----------------------------- 307
Chapter 33: Substance Use Disorders II: Alcohol --------------------------------------------- 315
Chapter 34: Substance Use Disorders III: Nicotine And Smoking ------------------------- 326
Chapter 35: Substance Use Disorders Iv: Major Drugs Of Abuse Other Than Alcohol
And Nicotine----------------------------------------------------------------------------------------- 335
UNIT IX: DRUGS THAT AFFECT THE HEART, BLOOD VESSELS, BLOOD, AND
BLOOD VOLUME ----------------------------------------------------------------------------- 351
Chapter 36: Review Of Hemodynamics --------------------------------------------------------- 351
Chapter 37: Diuretics ------------------------------------------------------------------------------ 358
Chapter 38: Drugs Acting On The Renin-Angiotensin-Aldosterone System -------------- 367
Chapter 39: Calcium Channel Blockers -------------------------------------------------------- 379
Chapter 40: Vasodilators -------------------------------------------------------------------------- 385
Chapter 41: Drugs For Hypertension ----------------------------------------------------------- 394
Chapter 42: Drugs For Heart Failure ----------------------------------------------------------- 410
Chapter 43: Antidysrhythmic Drugs ------------------------------------------------------------ 427
Chapter 44: Prophylaxis Of Atherosclerotic Cardiovascular Disease: Drugs That Help
Normalize Cholesterol And Triglyceride Levels----------------------------------------------- 445
Chapter 45: Drugs For Angina Pectoris -------------------------------------------------------- 461
Chapter 46: Anticoagulant and Antiplatelet Drugs ------------------------------------------- 477
Chapter 47: Drugs For Deficiency Anemias --------------------------------------------------- 492
UNIT X: DRUGS FOR ENDOCRINE DISORDERS ------------------------------------- 504
Chapter 48: Drugs For Diabetes ----------------------------------------------------------------- 504
Chapter 49: Drugs For Thyroid Disorders ----------------------------------------------------- 517
UNIT XI: REPRODUCTIVE HEALTH ---------------------------------------------------- 530
Chapter 50: Estrogens And Progestins: Basic Pharmacology And Noncontraceptive
Applications ----------------------------------------------------------------------------------------- 530
Chapter 51: Birth Control ------------------------------------------------------------------------ 537
Chapter 52: Androgens ---------------------------------------------------------------------------- 551
Chapter 53: Drugs for Benign Prostatic Hyperplasia ---------------------------------------- 560
Chapter 54. Drugs For Sexual Dysfunction ---------------------------------------------------- 566
Chapter 55. Transgender Health ----------------------------------------------------------------- 576
,UNIT XII: ANTI-INFLAMMATORY, ANTIALLERGIC, AND IMMUNOLOGIC
DRUGS ------------------------------------------------------------------------------------------ 600
Chapter 56: Review Of The Immune System -------------------------------------------------- 600
Chapter 57: Childhood Immunization ---------------------------------------------------------- 609
Chapter 58: Antihistamines ----------------------------------------------------------------------- 622
Chapter 59: Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs And
Acetaminophen ------------------------------------------------------------------------------------- 633
Chapter 60: Glucocorticoids In Nonendocrine Disorders------------------------------------ 646
UNIT XIII: DRUGS FOR BONE AND JOINT DISORDERS --------------------------- 659
Chapter 61: Drug Therapy Of Rheumatoid Arthritis ---------------------------------------- 659
Chapter 62: Drug Therapy Of Gout ------------------------------------------------------------- 667
Chapter 63: Drugs Affecting Calcium Levels And Bone Mineralization ------------------ 675
UNIT XIV: RESPIRATORY TRACT DRUGS --------------------------------------------- 688
Chapter 64: Drugs For Asthma And Chronic Obstructive Pulmonary Disease ---------- 688
Chapter 65: Drugs For Allergic Rhinitis, Cough, And Colds ------------------------------- 704
UNIT XV: GASTROINTESTINAL DRUGS ----------------------------------------------- 717
Chapter 66: Drugs For Peptic Ulcer Disease --------------------------------------------------- 717
Chapter 67: Laxatives ----------------------------------------------------------------------------- 727
Chapter 68: Other Gastrointestinal Drugs ----------------------------------------------------- 739
UNIT XVI: NUTRITION AND COMPLEMENTARY THERAPIES ------------------- 756
Chapter 69: Vitamins ------------------------------------------------------------------------------ 756
Chapter 70: Drugs for Obesity ------------------------------------------------------------------- 767
Chapter 71: Complementary And Alternative Therapies------------------------------------ 778
UNIT XVII: THERAPY FOR INFECTIOUS AND PARASITIC DISEASES--------- 786
Chapter 72: Basic Principles Of Antimicrobial Therapy ------------------------------------ 786
Chapter 73: Drugs That Weaken The Bacterial Cell Wall I: Penicillin’s ----------------- 795
Chapter 74: Drugs That Weaken The Bacterial Cell Wall Ii: Other Drugs -------------- 807
Chapter 75: Bacteriostatic Inhibitors Of Protein Synthesis --------------------------------- 817
Chapter 76: Aminoglycosides: Bactericidal Inhibitors Of Protein Synthesis ------------- 834
Chapter 77: Sulfonamide Antibiotics and Trimethoprim ------------------------------------ 848
Chapter 78: Drug Therapy Of Urinary Tract Infections ------------------------------------ 859
Chapter 79: Drugs Therapy For Tuberculosis ------------------------------------------------- 871
Chapter 80: Miscellaneous Antibacterial Drugs ---------------------------------------------- 886
Chapter 81: Antifungal Agents ------------------------------------------------------------------- 894
Chapter 82: Antiviral Agents I: Drugs For Non-Hiv Viral Infections --------------------- 911
Chapter 83: Antiviral Agents II: Drugs for HIV Infection ---------------------------------- 924
, Chapter 84: Drug Therapy for Sexually Transmitted Infections --------------------------- 935
Chapter 85: Anthelmintics ------------------------------------------------------------------------ 944
UNIT XVIII: CANCER THERAPY --------------------------------------------------------- 951
Chapter 86: Introduction To Immunomodulators -------------------------------------------- 951
Chapter 87: Supportive Care of Patients Receiving Anticancer Drugs -------------------- 960
Chapter 88: Drugs for Cancer Pain ------------------------------------------------------------- 973
UNIT XIX: DRUGS FOR EYES, EARS, AND SKIN ------------------------------------- 988
Chapter 89: Drugs for Disorders of the Eye --------------------------------------------------- 988
Chapter 90: Drugs for Disorders of the Skin -------------------------------------------------- 999
Chapter 91: Drugs for Disorders of the Ear ------------------------------------------------- 1016
UNIT XX: DRUG THERAPY IN ACUTE CARE --------------------------------------- 1027
Chapter 92: Agents Affecting The Volume And Ion Content Of Body Fluids ---------- 1027
Chapter 93: Management Of St-Elevation Myocardial Infarction ----------------------- 1037
Chapter 94: Drugs for Acute Care------------------------------------------------------------- 1048
,UNIT I: INTRODUCTION
Chapter 1: Prescriptive Authority
Rosenthal: Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants 3rd Edition, (2024) Test Bank
MULTIPLE CHOICE
1. What Is The Primary Purpose Of Prescriptive Authority For Advanced Practice
Nurses (APNS) And Physician Assistants (PAS)?
A) To Replace Physicians
B) To Enhance Patient Care And Access To Medications
C) To Increase Healthcare Costs
D) To Limit The Roles Of Physicians
Correct Answer: B) To Enhance Patient Care And Access To Medications
Rationale: Prescriptive Authority Allows APNS And PAS To Provide Timely
Medication Management, Improving Patient Access And Outcomes.
2. Which Factor Is Most Commonly Used To Determine The Extent Of
Prescriptive Authority For Apns And Pas?
A) Individual Training Programs
B) State Laws And Regulations
C) Hospital Policies
D) Patient Preferences
Correct Answer: B) State Laws And Regulations
Rationale: The Scope Of Prescriptive Authority Is Primarily Governed By State-
Specific Laws And Regulations.
,3. In Many States, Which Of The Following Is Required For An Np To Prescribe
Controlled Substances?
A) Completion Of A Residency Program
B) Certification From A National Board
C) DEA Registration
D) A Collaborative Agreement With A Pharmacist
Correct Answer: C) DEA Registration
Rationale: Prescribing Controlled Substances Requires Healthcare Providers To
Register With The Drug Enforcement Administration (DEA).
4. Which Of The Following Statements About Collaborative Practice
Agreements Is True?
A) They Are Only Necessary For PAS, Not NPS.
B) They Outline The Supervisory Relationship Between A Physician And An
APN Or PA.
C) They Limit The Medications That Can Be Prescribed.
D) They Are Optional In All States.
Correct Answer: B) They Outline The Supervisory Relationship Between A
Physician And An APN Or PA.
Rationale: Collaborative Practice Agreements Define The Working Relationship,
Including Prescribing Authority And Supervision Details.
5. Which Medication Class Is Most Likely To Require A Prescription?
A) Antacids
B) Antibiotics
,C) NSAIDS
D) Herbal Supplements
Correct Answer: B) Antibiotics
Rationale: Antibiotics Typically Require A Prescription Due To The Need For
Proper Diagnosis And Management Of Potential Side Effects.
6. What Is A Key Benefit Of E-Prescribing For APNS And Pas?
A) It Eliminates The Need For Patient Evaluations.
B) It Enhances Medication Adherence And Reduces Errors.
C) It Increases The Time Spent On Paperwork.
D) It Limits Access To Medications.
Correct Answer: B) It Enhances Medication Adherence And Reduces Errors.
Rationale: E-Prescribing Improves Accuracy And Efficiency, Helping To Ensure
Patients Receive The Correct Medications.
7. Which Of The Following Is Not A Common Requirement For Obtaining
Prescriptive Authority For APNS?
A) Advanced Pharmacology Coursework
B) National Certification
C) A Minimum Of Five Years Of Clinical Experience
D) State-Specific Licensure
Correct Answer: C) A Minimum Of Five Years Of Clinical Experience
Rationale: While Experience Is Valuable, Most States Do Not Require Five
Years Of Clinical Practice Specifically For Prescriptive Authority.
,8. What Role Do Formularies Play In Prescriptive Authority?
A) They Are Optional Lists Of Medications.
B) They Provide Guidelines On Prescribing Controlled Substances.
C) They Outline The Medications That Can Be Prescribed By APNS And Pas.
D) They Limit Prescribing To Generic Medications Only.
Correct Answer: C) They Outline The Medications That Can Be Prescribed By
APNS And PAS.
Rationale: Formularies Specify Which Medications Are Approved For Use By
Specific Providers, Guiding Their Prescribing Practices.
9. Which Of The Following Actions Could Lead To Disciplinary Action Against
An APN Or Pa Regarding Prescriptive Authority?
A) Prescribing A Medication Without A Valid Patient Relationship
B) Following A Collaborative Practice Agreement
C) Using E-Prescribing Systems Correctly
D) Consulting A Physician About Medication Management
Correct Answer: A) Prescribing A Medication Without A Valid Patient
Relationship
Rationale: Prescribing Without A Legitimate Patient-Provider Relationship
Violates Ethical And Legal Standards, Leading To Potential Disciplinary Actions.
10. What Is A Common Barrier To Effective Prescribing By APNS And PAS?
A) Access To Training Programs
B) Availability Of Medications
C) State Regulations That Limit Prescribing Authority
, D) Patient Trust
Correct Answer: C) State Regulations That Limit Prescribing Authority
Rationale: Variations In State Laws Can Restrict The Scope Of Practice And The
Ability To Prescribe Certain Medications.
11. Which Of The Following Is An Important Consideration When Prescribing
Medications?
A) Only The Physician's Preferences
B) The Patient's Medical History And Current Medications
C) Popular Trends In Pharmaceuticals
D) The Cost Of Medications Only
Correct Answer: B) The Patient's Medical History And Current Medications
Rationale: A Thorough Understanding Of A Patient's Medical History And
Current Medications Is Crucial For Safe And Effective Prescribing.
12. Which Of The Following Is True About Prescriptive Authority In Telehealth?
A) It Is Prohibited In All States.
B) It Has The Same Requirements As In-Person Visits.
C) It Allows For Easier Access To Medications Without Evaluations.
D) It Can Only Be Done For Non-Controlled Substances.
Correct Answer: B) It Has The Same Requirements As In-Person Visits.
Rationale: Prescriptive Authority In Telehealth Is Subject To The Same Legal
And Professional Standards As Traditional In-Person Visits.
